Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -32.947\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) CC(C)Cn1c(N2CCN(C(=O)/C=C/c3ccccc3)CC2)nc2ccccc21
b) COc1ccc(-c2nn(-c3ccccc3)cc2CN2CCCO2)c(F)c1
Answer: a. CC(C)Cn1c(N2CCN(C(=O)/C=C/c3ccccc3)CC2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)Cn1c(N2CCN(C(=O)/C=C/c3ccccc3)CC2)nc2ccccc21
CC(C)Cn1c(N2CCN(C(=O)/C=C/c3ccccc3)CC2)nc2ccccc21
(E)-1-[4-[1-(2-methylpropyl)benzimidazol-2-yl]piperazin-1-yl]-3-phenylprop-2-en-1-one